Enphase Energy, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Enphase inflated its revenues both within the United States and abroad. The Company utilized improper accounting of deferred revenue as part of this scheme. The increase in in gross margins reported by the Company were also inflated. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Enphase, investors suffered damages.

-->

Co-Diagnostics, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Co-Diagnostics knowingly spread misinformation about its COVID-19 diagnostic test to inflate its stock price while officers and executives exercised options and dumped their shares into the market. The Company’s statements about its product had no basis in scientific fact and were only designed to enrich Company insiders. Based on these facts, the Company’s public statements were false and materially misleading. When the market learned the truth about Co-Diagnostics, investors suffered damages.

-->

Forescout Technologies, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Forescout suffered from a severe decline in financial performance. This decline would have a material negative impact on the Company’s planned acquisition by Advent International Corp. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Forescout, investors suffered damages.

-->

Kandi Technologies Group, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Kandi was forced to make adjustments to multiple financial reports. The reports in question include its financial statements for the years ending December 31, 2015, and 2014, and the first three quarters for the year ended December 31, 2016. The Company failed to maintain appropriate controls on financial reporting. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Kandi, investors suffered damages.

-->

Hebron Technology Co., Ltd.

According to the Complaint, the Company made false and misleading statements to the market. Several of Hebron’s acquisitions, such as Beijing Hengpu and Nami Holding (Cayman) Co., Ltd., were actually deals with undisclosed related parties. The Company lacked sufficient controls over related-party transactions. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Hebron, investors suffered damages.

-->

Colony Capital, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Colony’s sale of its real estate portfolio and the splitting apart of Colony Credit Real Estate’s portfolio were likely to negatively impact the Company’s financial results. The Company’s remaining portfolio companies carried unsustainably high levels of debt secured by healthcare and hotel properties and were at a significant risk of default. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Colony, investors suffered damages.

-->

Brookdale Senior Living Inc.

According to the Complaint, the Company made false and misleading statements to the market. Brookdale sustained its financial performance throughout techniques such as intentionally understaffing its senior living communities. These techniques created a larger risk of litigation and would impact its financial performance when revealed. The Company’s financial performance was unsustainable. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Brookdale, investors suffered damages.

-->

Wells Fargo & Company

According to the Complaint, the Company made false and misleading statements to the market. Wells Fargo schemed to improperly allocate government-backed loans as part of the PPP program, and failed to maintain appropriate controls over its loans as part of the government program. This action left the company open to litigation risk as well as regulatory attention by the federal government. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Wells Fargo, investors suffered damages.

-->

Sorrento Therapeutics, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Sorrento announced an initial finding of “100% inhibition” of an in vitro virus infection, but this finding will not necessarily translate to safety or success in person or in vivo. The Company did not find a “cure” for COVID-19. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Sorrento, investors suffered damages.

-->

CytomX Therapeutics, Inc.

According to the Complaint, the Company made false and misleading statements to the market. CytomX minimized problems with its drug candidate CX-072’s efficacy as documented in its PROCLAIM-CX-072 clinical program. The Company also downplayed CX-2009’s efficacy and safety problems as observed in the PROCLAIM-CX-2009 clinical program. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about CytomX, investors suffered damages.

-->